ID   Mel Ibr subclone
AC   CVCL_B6KC
DR   cancercelllines; CVCL_B6KC
DR   Wikidata; Q112129271
RX   PubMed=26388567;
RX   PubMed=28726209;
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6JK ! Mel Ibr
SX   Female
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=26388567; DOI=10.1007/s10517-015-3007-5;
RA   Suraeva N.M., Morozova L.F., Samoilov A.V., Burova O.S.,
RA   Golubeva V.A., Baryshnikova M.A., Baryshnikov A.Y.;
RT   "Changes in the morphological and immunological characteristics of Mel
RT   Ibr melanoma cells in response to chicken embryo extract.";
RL   Bull. Exp. Biol. Med. 159:520-523(2015).
//
RX   PubMed=28726209; DOI=10.1007/s10517-017-3778-y;
RA   Suraeva N.M., Morozova L.F., Ryabaya O.O., Khochenkova Y.A.,
RA   Samoilov A.V., Burova O.S., Golubtsova N.V., Barmashov A.E.,
RA   Baryshnikova M.A.;
RT   "Characteristics of Mel Ibr melanoma line subclone after treatment
RT   with chicken embryo extract.";
RL   Bull. Exp. Biol. Med. 163:255-259(2017).
//